1 - 15 of 204 Results Clear All
New research sheds light on the biological effect of the many possible three-dimensional structures of a critical loop of RNA in HIV
Research (Publication) HIV/AIDS Virology Ott Lab
The Atlantic—The next generation of COVID vaccines may be directed against just one lineage of the Omicron strain. Melanie Ott, director of the Gladstone Institute of Virology, explains why that could be a smart strategy to elicit a strong immune response.
Gladstone Experts COVID-19 Virology Ott Lab
San Francisco Chronicle—Gladstone Senior Investigator Nadia Roan explains that while prior vaccination or exposure to COVID-19 may confer long-term protection against serious disease, a booster shot with the bivalent vaccine will protect you for a few months against new infection.
Gladstone Experts COVID-19 Virology Roan Lab
Colleagues look back on Warner Greene's 40 year career
Gladstone Experts History HIV/AIDS Virology Greene Lab
Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab
San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.
Gladstone Experts COVID-19 Virology Roan Lab
Revisit some of Gladstone’s most important stories from the past year
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Genomic Immunology Neurological Disease Virology
San Francisco Chronicle—Although requirements for mask wearing and social distancing have eased around the country, a third winter of the pandemic is looming. Gladstone Senior Investigator Warner Greene recommends paying attention to local trends in case numbers to decide which COVID-19 precautions to take.
Gladstone Experts COVID-19 Virology Greene Lab
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, shares his views on the likelihood of a new COVID surge this winter.
Gladstone Experts COVID-19 Virology Greene Lab
Invisishield Technologies—Gladstone Senior Investigator Warner Greene has been appointed President and Chief Scientific Officer of Invisihield Technologies. Invisishield is focused on developing intranasal preventatives for respiratory viruses, including SARS-CoV-2.
Gladstone Experts COVID-19 Virology Greene Lab
ABC7 News—Senior Investigator Nadia Roan, PhD, says that a winter surge of infections from the highly transmissible new variants of SARS-CoV-2 currently emerging in the US is likely, but it remains unclear how bad it will be.
Gladstone Experts COVID-19 Virology Roan Lab
San Francisco Chronicle—The new bivalent COVID-19 booster shots are recommended for individuals age 5 and up who are at least two months past their last vaccine dose. Gladstone Investigator Nadia Roan explains that the bivalent boosters greatly increase the levels of antibodies that can prevent the Omicron variant from infecting cells.
Gladstone Experts COVID-19 Virology Roan Lab
San Francisco Chronicle—New COVID-19 booster shots targeting both the ancestral virus and omicron strains are now available. Gladstone Investigator Nadia Roan weighs in on when people should get the jab, based on the timing of their last dose and whether they’ve been recently infected.
Gladstone Experts COVID-19 Virology Roan Lab
The single-dose, intranasal treatment also reduces symptoms of multiple variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Center for Cell Circuitry Virology Weinberger Lab Chaturvedi
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, says that it makes more sense to boost immunity with the newly approved bivalent vaccines targeting Omicron than with vaccines that aim at long-extinct variants of the coronavirus.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab
